5-carbamoyl-1h-imidazol-4-yl-piperonylate has been researched along with floxuridine in 1 studies
*Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. [MeSH]
*Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. [MeSH]
| Studies (5-carbamoyl-1h-imidazol-4-yl-piperonylate) | Trials (5-carbamoyl-1h-imidazol-4-yl-piperonylate) | Recent Studies (post-2010) (5-carbamoyl-1h-imidazol-4-yl-piperonylate) | Studies (floxuridine) | Trials (floxuridine) | Recent Studies (post-2010) (floxuridine) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 3,556 | 323 | 280 |
| Protein | Taxonomy | 5-carbamoyl-1h-imidazol-4-yl-piperonylate (IC50) | floxuridine (IC50) |
|---|---|---|---|
| Thymidylate synthase | Mus musculus (house mouse) | 1.0862 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsukagoshi, S | 1 |
1 other study(ies) available for 5-carbamoyl-1h-imidazol-4-yl-piperonylate and floxuridine
| Article | Year |
|---|---|
Overview of new anticancer drugs of interest in Japan.
Topics: Antineoplastic Agents; Doxorubicin; Floxuridine; Humans; Imidazoles; Japan | 1980 |